• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.
    All News #Library

    Enforcement Report - Week of June 4, 2025

    FDA

    Bayer to Share New Data from KERENDIA Trial at Renal Congress

    BUSINESSWIRE

    Fujirebio launches Lumipulse G sTREM2 Assay for Research

    BUSINESSWIRE

    Merus N.V. Announces Pricing of Public Offering of Common Shares

    GLOBENEWSWIRE

    Moderna to Conduct True Placebo Trial for New Covid Vaccine

    REUTERS

    Roche & Jazz Link Drug Combo to Improve Survival in Ph 3 Trial

    BIOSPACE

    Indoco Launches Ticagrelor Tablets 90mg in UK Market

    EXPRESSPHARMA

    Sun Pharma Stops SCD-044 Drug Development Due to Trial Results

    BUSINESS STD

    Zydus Partners with Agenus for Cancer Therapies in India

    BUSINESSWIRE

    Merck made $3B offer for MoonLake & could revive interest

    FINANCIALTIMES

    Transpire licenses PDE4 inhibitor for lung disease

    FIERCE BIOTECH

    BioAge inks Option Agreement for Chinese biotech`s Obesity Asset

    FIERCE BIOTECH

    Zhejiang Easyclean Daily Chemical Recieves Warning Letter

    FDA

    Evi Labs Recieves Warning Letter

    FDA

    Yiling Pharmaceutical Recieves Warning Letter

    FDA

    CTK OTC Laboratories Recieves Warning Letter

    FDA

    Rechon Life Science Recieves Warning Letter

    FDA

    McKesson Corporation Completes Acquisition of Core Ventures

    BUSINESSWIRE

    Estrella Immunopharma Announces $3.35M Private Placement

    BUSINESSWIRE

    Rimkus Welcomes Dr. Gavin to Enhance Human Factors Expertise

    BUSINESSWIRE

    Aegis Sciences Updates Novel Psychoactive Substances Testing

    BUSINESSWIRE

    Braskem and Ardent Advance Olefin Separation Technology

    BUSINESSWIRE

    Haya Therapeutics Moves San Diego Operations to Lilly Gateway Lab

    BUSINESSWIRE

    Integral Announces Timothy Nobles as Chief Product Officer

    BUSINESSWIRE

    FDA Grants Breakthrough Designation to Guardant Health’s MCD Test

    BUSINESSWIRE

    Kairos Pharma Reveals Promising Cancer Immunotherapy Data

    BUSINESSWIRE

    Prostate Cancer Foundation Starts 30th Annual Home Run Challenge

    BUSINESSWIRE

    Orbis Boosts Oral Macrocycle Platform With Gefion AI

    BUSINESSWIRE

    LEO Pharma Begins Phase 2a Delta Next Trial of Delgocitinib Cream

    BUSINESSWIRE

    Leyden Labs secures €20M EIB Investment for Pandemic Preparedness

    BUSINESSWIRE

    MarkHerz, TUM Hospital sign MOU for Cardiovascular and Diabetes

    BUSINESSWIRE

    Auragens Named Nevada Business of the Year 2025

    BUSINESSWIRE

    Token Launches BioKey for Enterprise-Grade MFA

    BUSINESSWIRE

    Alto Neuroscience Acquires Dopamine Agonist for Depression Study

    BUSINESSWIRE

    Byondis Doses First Patient in BYON4228 Phase 1 Trial

    BUSINESSWIRE

    PharmaEssentia to Present at EHA on Myeloproliferative Neoplasms

    BUSINESSWIRE

    Bruker Acquires biocrates, Leader in Mass Spectrometry

    BUSINESSWIRE

    908 Devices’ XplorIR Added to DC Hazmat Toolkit

    BUSINESSWIRE

    Innoviva to Participate in Upcoming Investor Conferences

    BUSINESSWIRE

    Amylyx Pharmaceuticals Gets FDA Fast Track for AMX0114 for ALS

    BUSINESSWIRE

    NationsBenefits Adds Discount Drug Mart Access

    BUSINESSWIRE

    FineHeart gets ANSM Authorization for first human study in France

    BUSINESSWIRE

    Hims & Hers to Acquire ZAVA, Accelerating European Growth in UK

    BUSINESSWIRE

    ZAP Surgical Launches ZAP-X Radiosurgery Program in Mexico

    BUSINESSWIRE

    Cybin Announces U.S. Patent for CYB004 in Phase 2 for Anxiety

    BUSINESSWIRE

    Redwire Gets Contract from Aspera Biomed for Cancer Treatment

    BUSINESSWIRE

    Xeris Reveals Long-Term Growth Strategy at 2025 Investor Day

    BUSINESSWIRE

    Ability Biotherapeutics Welcomes Angèle Maki, PhD to Board

    BUSINESSWIRE

    Affinia Therapeutics and DCM Foundation Partner to Raise Awarenes

    BUSINESSWIRE

    Geneoscopy`s RNA-Based ColoSense Test in Latest NCCN Guidelines

    BUSINESSWIRE

    TRI Overhauls OPRA-CM to Enhance Clinical Trial Monitoring

    BUSINESSWIRE

    Nutcracker Debuts NMU-Symphony RNA Manufacturing Tech

    BUSINESSWIRE

    Tenpoint`s NDA for Brimchol PF Accepted by FDA

    BUSINESSWIRE

    ASCO Report: Treatment of Lymphopenia Benefits Pancreatic Cancer

    BUSINESSWIRE

    USPTO Veteran Jean Witz Joins Wilson Sonsini Life Sciences

    BUSINESSWIRE

    Pheast gets FDA Fast Track for PHST001 in Ovarian Cancer

    BUSINESSWIRE

    TRexBio Doses First Participant in Phase 1 Trial of TRB-061

    BUSINESSWIRE

    bioAffinity Technologies Partners with Cardinal Health for CyPath

    BUSINESSWIRE

    Avenzo Therapeutics Begins Phase 1/2 Study of AVZO-1418

    BUSINESSWIRE

    Enveric Biosciences Issues US Patent for Novel Molecules

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.